Showing results (5531-5540 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|September 25, 2025
Immune checkpoint Inhibitor-Related Myocarditis: A Comprehensive Analysis of Clinical Manifestations and Prognostic FactorsYue Fan, Yan Xu, Xiaoyan Liu, et al.
The Oncologist|September 19, 2025
Enhancing the interpretation of real-world quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer enrolled in the POLARIS studyGabrielle B Rocque, Joanne L Blum, Yan Ji, et al.
The Oncologist|September 19, 2025
Determining the Cancer Center priorities at the Wilmot Cancer Institute: A proposed framework informed by an academic-community collaborative approachFrancisco Cartujano-Barrera, Ana Paula Cupertino, Emily Hayes, et al.
The Oncologist|September 19, 2025
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium StudyDeirdre J Cohen, Judith D Goldberg, Lawrence Leichman, et al.
The Oncologist|May 16, 2025
Navigating challenging patient factors in systemic therapy for head and neck cancerPetr Szturz, Robert I Haddad, Marshall Posner, et al.
The Oncologist|May 16, 2025
Systemic anticancer therapy at the end of life: real-world insights from a tertiary oncology center in IsraelRenana Barak, Esraa Safadi, Alla Nikolaevski-Berlin, et al.
The Oncologist|May 16, 2025
Using ex vivo radioactivity measurement to differentiate parathyroid single-gland and multigland diseaseRongzhi Wang, Zhixing Song, Claren Harper, et al.
The Oncologist|May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancerVincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
The Oncologist|May 11, 2025
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer networkNicolas Rippstein, Christophe Zemmour, Manuel Rodrigues, et al.
The Oncologist|May 11, 2025
Evaluation of the effectiveness and safety of avapritinib in real-world Spanish cases with gastrointestinal stromal tumor and D842V-PDGFRA mutationIsaac Nuñez Hernández, Cristina Gómez Palmero, Juan Ramón Delgado, et al.
Pageof 571